Sign inJoin waitlistJoin the waitlist

Nicholas Whipple

Associate Professor · Univ of Utah Sch of Med

Credentials: · · · · · ·

History

Univ of Utah Sch of Med
Present

St Jude Children's Research Hospital
2017–2018
Pediatric Hematology Oncology
St Jude Children's Research Hospital
2014–2017
Pediatrics
University of Utah School of Medicine
2011–2014
Milken Institute School of Public Health at George Washington University
University of Mississippi School of Medicine
2006–2010
University of Mississippi
2002–2006

Research

The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial
Nature Medicine · 2024 · 168 citations
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)
Neuro-Oncology · 2022 · 112 citations
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma
Journal of Clinical Investigation · 2020 · 103 citations

David Solomon
7 papers
Arie Perry
5 papers · 3 as a fellow
Calixto-Hope Lucas
5 papers · 5 as a resident
Carol Bruggers
5 papers
Joanna Phillips
5 papers
Sabine Mueller
5 papers
Samuel Cheshier
5 papers
Amar Gajjar
4 papers
AF
Andrea Franson
4 papers
Andrew Bollen
4 papers · 2 as a fellow
Anuradha Banerjee
4 papers
Cassie Kline
4 papers

Clinical trials

Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors
Study chair · Completed · Phase 1
University of California, San Francisco
2022–2024
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
Site PI · Recruiting · Phase 2
University of California, San Francisco
2025–2032
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Site PI · Recruiting · Phase 2
St. Jude Children's Research Hospital
2022–2035
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Site PI · Recruiting · Phase 2
Sabine Mueller, MD, PhD
2022–2028